Revance Therapeutics Inc. (RVNC) Moves Higher on Volume Spike for November 16

Equities Staff |

Revance Therapeutics Inc. (RVNC) traded on unusually high volume on Nov. 16, as the stock gained 2.2% to close at $25.50. On the day, Revance Therapeutics Inc. saw 316,880 shares trade hands on 2,597 trades. Considering that the stock averages only a daily volume of 148,476 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $28.75 and $15.85 over the last 52-weeks, its 50-day SMA is now $26.06, and its 200-day SMA $23.13. Revance Therapeutics Inc. has a P/B ratio of 5.56.

Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

Headquartered in Newark, CA, Revance Therapeutics Inc. has 126 employees and is currently under the leadership of CEO L. Daniel Browne.

For a complete fundamental analysis analysis of Revance Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for RVNC.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

To get more information on Revance Therapeutics Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: RVNC’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Lomiko Metals Inc.

Lomiko Metals Inc is an exploration stage company. It is engaged in the acquisition, exploration and development of resource properties. Its projects include Vines Lake project and Quatre - Milles…

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…